LE WE PMID CA
COPD587COPD

Aclidinium

Anticholinergic agents

Antiinflammatory compounds

Artificial ventilation (non invasive)

Asthma (BASKET)

Asthma (occupational)

Atherosclerosis (BASKET)

Autonomous nervous system (Dysautonomia)

bBeta adrenergic agonists

BOOP

Cachexia (Pulmonary)

Carmoterol

Cilia

Clinical examination (Lung)

COPD

Cystic fibrosis

Dendritic cell (Immunology)

Depression

ERS UFR (Diseases)

Germinal center (ectopic)

Haemophilus influenzae

Heart (Coronary heart disease BASKET)

History of medicine

Ibudilast

Indacaterol

Inhalers

Lebensverlaengernde Massnahmen

Lung (CT)

Lung (Development)

Lung (Imaging)

Lung (Pathology)

Lung and bronchial system (Malformation)

Lung and bronchial system (Neoplasia)

Macrolide

Nicotine

Nrf2

Osteoporosis

Palliative Medicine

PAR2

PDE phosphodiesterase

PDE3

PDE4

Premedication and perioperative medicine

Proteasome (BASKET)

PSMB6

Pulmonary function testing

Pulmonary hypertension

Remodeling

Roflumilast ttPDE4

S Carboxymethylcysteine

Silicon

Sleep apnea (obstructive)

Sputum

Statin

Sulforaphane

T cell (Th17)

Theophylline

TRPV4

Ventilation (Heliox)

Vitamin D

2006  
1
ABC of chronic obstructive pulmonary disease. Acute exacerbations.
[16825232] BMJ 333(7558): 87-9 (2006)
2006  
2
ABC of chronic obstructive pulmonary disease. Pharmacological management--oral treatment.
[16793814] BMJ 332(7556): 1497-9 (2006)
2006  
3
ABC of chronic obstructive pulmonary disease.Non-pharmacological management.
[16763252] BMJ 332(7554): 1379-81 (2006)
2006  
4
ABC of chronic obstructive pulmonary disease. Diagnosis.
[16735338] BMJ 332(7552): 1261-3 (2006)
2006  
5
ABC of chronic obstructive pulmonary disease. Definition, epidemiology, and risk factors.
[16690673] BMJ 332(7550): 1142-4 (2006)
2009  
6
Clinical definition of COPD exacerbations and classification of their severity.
[19204646] South Med J 102(3): 277-82 (2009)
2009  
7
Toward a standardized definition and severity classification of COPD exacerbations.
[19204643] South Med J 102(3): 233-4 (2009)
2008  
8
Advanced chronic obstructive pulmonary disease: rethinking models of care.
[18669555] QJM 101(9): 697-704 (2008)
2005  
9
Initial oxygen management in patients with an exacerbation of chronic obstructive pulmonary disease.
[15955796] QJM 98(7): 499-504 (2005)
2006  
10
Home oxygen therapy in COPD patients. Results from the Danish Oxygen Register 1994-2000.
[17092451] Dan Med Bull 53(3): 310-25 (2006)
2002  
11
Corticosteroid therapy for patients with acute exacerbations of chronic obstructive pulmonary disease: a systematic review.
[12456224] Arch Intern Med 162(22): 2527-36 (2002)
2007  
12
Aspects on pathophysiological mechanisms in COPD.
[17697154] J Intern Med 262(3): 311-40 (2007)
2008  
13
Approach to chronic obstructive pulmonary disease in primary care.
[18474704] Can Fam Physician 54(5): 706-11 (2008)
2007  
14
Should we avoid beta-agonists for moderate and severe chronic obstructive pulmonary disease? YES.
[17872838] Can Fam Physician 53(8): 1290-7 (2007)
2006  
15
Best evidence topic report. Administration of steroids in acute exacerbations of COPD.
[16439750] Emerg Med J 23(2): 142-3 (2006)
2004  
16
Mediators of chronic obstructive pulmonary disease.
[15602009] Pharmacol Rev 56(4): 515-48 (2004)
2005  
17
2004  
18
Chronic obstructive pulmonary disease treatment options.
[15253682] J Manag Care Pharm 10(4 Suppl): S11-6 (2004)
2004  
19
Chronic obstructive pulmonary disease overview: prevalence, pathogenesis, and treatment.
[15253681] J Manag Care Pharm 10(4 Suppl): S3-10 (2004)
2009  
20
Update on pulmonary hypertension complicating chronic obstructive pulmonary disease.
[19802350] Int J Chron Obstruct Pulmon Dis 4(-): 351-63 (2009)
2009  
21
Markers of early disease and prognosis in COPD.
[19436688] Int J Chron Obstruct Pulmon Dis 4(-): 157-67 (2009)
2008  
22
Role of macrolide therapy in chronic obstructive pulmonary disease.
[18990961] Int J Chron Obstruct Pulmon Dis 3(3): 331-50 (2008)
2008  
23
2008  
24
Pulmonary hypertension associated with COPD.
[18488429] Int J Chron Obstruct Pulmon Dis 3(1): 55-70 (2008)
2008  
25
The role for S-carboxymethylcysteine (carbocisteine) in the management of chronic obstructive pulmonary disease.
[19281081] Int J Chron Obstruct Pulmon Dis 3(4): 659-69 (2008)
2008  
26
Lung volume reduction surgery and lung transplantation in chronic obstructive pulmonary disease.
[19281079] Int J Chron Obstruct Pulmon Dis 3(4): 629-35 (2008)
2008  
27
Treatment of mild chronic obstructive pulmonary disease.
[19281074] Int J Chron Obstruct Pulmon Dis 3(4): 563-73 (2008)
2008  
28
Use of azithromycin in the treatment of acute exacerbations of COPD.
[19281070] Int J Chron Obstruct Pulmon Dis 3(4): 515-20 (2008)
2007  
29
A new staging strategy for chronic obstructive pulmonary disease.
[18268941] Int J Chron Obstruct Pulmon Dis 2(4): 657-63 (2007)
2007  
30
Beta-blockers use in patients with chronic obstructive pulmonary disease and concomitant cardiovascular conditions.
[18268926] Int J Chron Obstruct Pulmon Dis 2(4): 535-40 (2007)
2007  
31
2007  
32
Pathophysiology of viral-induced exacerbations of COPD.
[18268922] Int J Chron Obstruct Pulmon Dis 2(4): 477-83 (2007)
2007  
33
Non-invasive ventilation in exacerbations of COPD.
[18268921] Int J Chron Obstruct Pulmon Dis 2(4): 471-6 (2007)
2007  
34
Review of ventilatory techniques to optimize mechanical ventilation in acute exacerbation of chronic obstructive pulmonary disease.
[18268918] Int J Chron Obstruct Pulmon Dis 2(4): 441-52 (2007)
2007  
35
Clinical use of exhaled biomarkers in COPD.
[18268915] Int J Chron Obstruct Pulmon Dis 2(4): 403-8 (2007)
2007  
36
New insights on COPD imaging via CT and MRI.
[18229568] Int J Chron Obstruct Pulmon Dis 2(3): 301-12 (2007)
2007  
37
Factors contributing to muscle wasting and dysfunction in COPD patients.
[18229567] Int J Chron Obstruct Pulmon Dis 2(3): 289-300 (2007)
2007  
38
Pulmonary hypertension and chronic cor pulmonale in COPD.
[18229565] Int J Chron Obstruct Pulmon Dis 2(3): 273-82 (2007)
2007  
39
Moxifloxacin in the management of exacerbations of chronic bronchitis and COPD.
[18229559] Int J Chron Obstruct Pulmon Dis 2(3): 191-204 (2007)
2007  
40
2007  
41
PDE4 inhibitors as potential therapeutic agents in the treatment of COPD-focus on roflumilast.
[18044684] Int J Chron Obstruct Pulmon Dis 2(2): 121-9 (2007)
2007  
42
The development of anticholinergics in the management of COPD.
[18044064] Int J Chron Obstruct Pulmon Dis 2(1): 33-40 (2007)
2007  
43
Respiratory muscles training in COPD patients.
[18044062] Int J Chron Obstruct Pulmon Dis 2(1): 19-25 (2007)
2007  
44
Bronchodilators in COPD: impact of beta-agonists and anticholinergics on severe exacerbations and mortality.
[18044061] Int J Chron Obstruct Pulmon Dis 2(1): 11-8 (2007)
2006  
45
Clinical implications of airway hyperresponsiveness in COPD.
[18046902] Int J Chron Obstruct Pulmon Dis 1(1): 49-60 (2006)
2006  
46
Eosinophilic airway inflammation in COPD.
[18046901] Int J Chron Obstruct Pulmon Dis 1(1): 39-47 (2006)
2006  
47
2006  
48
Apoptotic mechanisms in the pathogenesis of COPD.
[18046893] Int J Chron Obstruct Pulmon Dis 1(2): 161-71 (2006)
2006  
49
Current status of noninvasive ventilation in stable COPD patients.
[18046890] Int J Chron Obstruct Pulmon Dis 1(2): 129-35 (2006)
2006  
50
Role of mucolytics in the management of COPD.
[18046889] Int J Chron Obstruct Pulmon Dis 1(2): 123-8 (2006)
2006  
51
Budesonide-formoterol (inhalation powder) in the treatment of COPD.
[18046888] Int J Chron Obstruct Pulmon Dis 1(2): 115-22 (2006)
2006  
52
The role for N-acetylcysteine in the management of COPD.
[18046886] Int J Chron Obstruct Pulmon Dis 1(2): 99-106 (2006)
2006  
53
Strategies for improving outcomes of COPD exacerbations.
[18046870] Int J Chron Obstruct Pulmon Dis 1(3): 335-42 (2006)
2006  
54
Biological targets for therapeutic interventions in COPD: clinical potential.
[18046869] Int J Chron Obstruct Pulmon Dis 1(3): 321-34 (2006)
2006  
55
Palliative management of refractory dyspnea in COPD.
[18046866] Int J Chron Obstruct Pulmon Dis 1(3): 289-304 (2006)
2006  
56
A meta-analysis on the efficacy of oral theophylline in patients with stable COPD.
[18046863] Int J Chron Obstruct Pulmon Dis 1(3): 261-6 (2006)
2006  
57
Newer fluoroquinolones in the treatment of acute exacerbations of COPD.
[18046861] Int J Chron Obstruct Pulmon Dis 1(3): 243-50 (2006)
2006  
58
Salmeterol/fluticasone combination in the treatment of COPD.
[18046860] Int J Chron Obstruct Pulmon Dis 1(3): 235-42 (2006)
2006  
59
2006  
60
The severity of airways obstruction as a determinant of treatment response in COPD.
[18046858] Int J Chron Obstruct Pulmon Dis 1(3): 209-18 (2006)
2006  
61
The benefits of combined treatment with corticosteroids and long-acting beta agonists.
[18046857] Int J Chron Obstruct Pulmon Dis 1(3): 207-8 (2006)
2006  
62
Role of N-acetylcysteine in the management of COPD.
[18044098] Int J Chron Obstruct Pulmon Dis 1(4): 425-34 (2006)
2006  
63
Pharmacological treatment of chronic obstructive pulmonary disease.
[18044097] Int J Chron Obstruct Pulmon Dis 1(4): 409-23 (2006)
2006  
64
Hyperinflation and its management in COPD.
[18044095] Int J Chron Obstruct Pulmon Dis 1(4): 381-400 (2006)
2006  
65
2006  
66
Is there any treatment other than drugs to alleviate dyspnea in COPD patients?
[18044092] Int J Chron Obstruct Pulmon Dis 1(4): 355-61 (2006)
2006  
67
The role of combination therapy with corticosteroids and long-acting beta2-agonists in the prevention of exacerbations in COPD.
[18044091] Int J Chron Obstruct Pulmon Dis 1(4): 345-54 (2006)
2006  
68
2009  
69
Chronic obstructive pulmonary disease: evidence for an autoimmune component.
[19403056] Cell Mol Immunol 6(2): 81-6 (2009)
2006  
70
Pathology of chronic obstructive pulmonary disease.
[16554918] Pathol Oncol Res 12(1): 52-60 (2006)
2007  
71
Pathobiology of cigarette smoke-induced chronic obstructive pulmonary disease.
[17615396] Physiol Rev 87(3): 1047-82 (2007)
2009  
72
Cost-effectiveness of long-term oxygen therapy for chronic obstructive disease.
[19284806] Am J Manag Care 15(2): 97-104 (2009)
2004  
73
An assessment of therapeutic regimens in the treatment of acute exacerbations in chronic obstructive pulmonary disease and asthma.
[15354679] Am J Manag Care 10(5 Suppl): S139-52 (2004)
2004  
74
Epidemiology, clinical and economic burden, and natural history of chronic obstructive pulmonary disease and asthma.
[15354678] Am J Manag Care 10(5 Suppl): S129-38 (2004)
2000  
75
The role of infection in acute exacerbations of chronic obstructive pulmonary disease.
[10977482] Am J Manag Care 6(8 Suppl): S427-36 (2000)
2008  
76
Animal models of chronic obstructive pulmonary disease.
[18456796] Am J Physiol Lung Cell Mol Physiol 295(1): L1-15 (2008)
2008  
77
Mechanisms of cigarette smoke-induced COPD: insights from animal models.
[18223159] Am J Physiol Lung Cell Mol Physiol 294(4): L612-31 (2008)
2005  
78
Pulmonary rehabilitation in chronic obstructive pulmonary disease.
[15778487] Am J Respir Crit Care Med 172(1): 19-38 (2005)
2004  
79
The GOLD classification has not advanced understanding of COPD.
[15280172] Am J Respir Crit Care Med 170(3): 212-3; discussion 214 (2004)
2004  
80
The GOLD classification has advanced understanding of COPD.
[15280171] Am J Respir Crit Care Med 170(3): 211-2; discussion 214 (2004)
2009  
81
ACP Journal Club. Review: Inhaled corticosteroids do not reduce mortality but increase pneumonia in chronic obstructive pulmonary disease.
[19306488] Ann Intern Med 150(6): JC3-6 (2009)
2009  
82
ACP Journal Club. Review: Inhaled anticholinergics increase risk for major cardiovascular events in chronic obstructive pulmonary disease.
[19172711] Ann Intern Med 150(2): JC1-6, JC1-7 (2009)
2008  
83
Screening for chronic obstructive pulmonary disease using spirometry: U.S. Preventive Services Task Force recommendation statement.
[18316747] Ann Intern Med 148(7): 529-34 (2008)
2008  
84
In the clinic. Chronic obstructive pulmonary disease.
[18316750] Ann Intern Med 148(5): ITC3-1-ITC3-16 (2008)
2007  
85
Management of stable chronic obstructive pulmonary disease: a systematic review for a clinical practice guideline.
[17975187] Ann Intern Med 147(9): 639-53 (2007)
2007  
86
Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline from the American College of Physicians.
[17975186] Ann Intern Med 147(9): 633-8 (2007)
2006  
87
Quality of care for patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease.
[16785478] Ann Intern Med 144(12): 894-903 (2006)
2004  
88
Noninvasive ventilation in exacerbations of chronic obstructive pulmonary disease: implications of different meta-analytic strategies.
[15353447] Ann Intern Med 141(5): W78-9 (2004)
2003  
89
Long-term effects of inhaled corticosteroids on FEV1 in patients with chronic obstructive pulmonary disease. A meta-analysis.
[12809453] Ann Intern Med 138(12): 969-73 (2003)
2003  
90
Which patients with acute exacerbation of chronic obstructive pulmonary disease benefit from noninvasive positive-pressure ventilation? A systematic review of the literature.
[12779296] Ann Intern Med 138(11): 861-70 (2003)
2002  
91
Cardioselective beta-blockers in patients with reactive airway disease: a meta-analysis.
[12416945] Ann Intern Med 137(9): 715-25 (2002)
2001  
92
Management of acute exacerbations of chronic obstructive pulmonary disease: a summary and appraisal of published evidence.
[11281745] Ann Intern Med 134(7): 600-20 (2001)
2001  
93
Evidence base for management of acute exacerbations of chronic obstructive pulmonary disease.
[11281744] Ann Intern Med 134(7): 595-9 (2001)
2009  
94
COPD as a disease of accelerated lung aging.
[19136405] Chest 135(1): 173-80 (2009)
2008  
95
Pulmonary vascular involvement in COPD.
[18842913] Chest 134(4): 808-14 (2008)
2008  
96
Update on the management of COPD.
[18574288] Chest 133(6): 1451-62 (2008)
2008  
97
Contemporary management of acute exacerbations of COPD: a systematic review and metaanalysis.
[18321904] Chest 133(3): 756-66 (2008)
2006  
98
How viral infections cause exacerbation of airway diseases.
[17035457] Chest 130(4): 1203-10 (2006)
2006  
99
Structural changes in airway diseases: characteristics, mechanisms, consequences, and pharmacologic modulation.
[16608960] Chest 129(4): 1068-87 (2006)
2001  
100
Management of acute exacerbations of COPD: a summary and appraisal of published evidence.
[11296189] Chest 119(4): 1190-209 (2001)
2001  
101
The evidence base for management of acute exacerbations of COPD: clinical practice guideline, part 1.
[11296188] Chest 119(4): 1185-9 (2001)
2008  
102
Exhaled breath condensate biomarkers in COPD.
[18669788] Eur Respir J 32(2): 472-86 (2008)
2008  
103
Nonpharmacological treatment and relief of symptoms in COPD.
[18591339] Eur Respir J 32(1): 218-28 (2008)
2008  
104
Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction.
[18515558] Eur Respir J 31(6): 1334-56 (2008)
2008  
105
Drugs (including oxygen) in severe COPD.
[18448506] Eur Respir J 31(5): 1114-24 (2008)
2008  
106
Remodelling of peripheral lung tissue in COPD.
[18448496] Eur Respir J 31(5): 913-4 (2008)
2008  
107
Peroxisome proliferator-activated receptors: a therapeutic target in COPD?
[18310397] Eur Respir J 31(3): 502-8 (2008)
2008  
108
Outcomes for COPD pharmacological trials: from lung function to biomarkers.
[18238951] Eur Respir J 31(2): 416-69 (2008)
2008  
109
Complex chronic comorbidities of COPD.
[18166598] Eur Respir J 31(1): 204-12 (2008)
2007  
110
Definition, epidemiology and natural history of COPD.
[17978157] Eur Respir J 30(5): 993-1013 (2007)
2007  
111
Exacerbations of chronic obstructive pulmonary disease.
[17540785] Eur Respir J 29(6): 1224-38 (2007)
2006  
112
Mortality in COPD: Role of comorbidities.
[17138679] Eur Respir J 28(6): 1245-57 (2006)
2006  
113
Oxidative stress and redox regulation of lung inflammation in COPD.
[16816350] Eur Respir J 28(1): 219-42 (2006)
2006  
114
Outcomes and markers in the assessment of chronic obstructive pulmonary disease.
[16585091] Eur Respir J 27(4): 822-32 (2006)
2006  
115
The natural history of chronic obstructive pulmonary disease.
[16507865] Eur Respir J 27(3): 627-43 (2006)
2005  
116
COPD: current therapeutic interventions and future approaches.
[15929966] Eur Respir J 25(6): 1084-106 (2005)
2004  
117
New strategies to improve exercise tolerance in chronic obstructive pulmonary disease.
[15332404] Eur Respir J 24(2): 313-22 (2004)
2004  
118
Let's not forget: the GOLD criteria for COPD are based on post-bronchodilator FEV1.
[15083741] Eur Respir J 23(4): 497-8 (2004)
2003  
119
Chronic obstructive pulmonary disease: molecular and cellular mechanisms.
[14582923] Eur Respir J 22(4): 672-88 (2003)
2003  
120
Pulmonary hypertension in chronic obstructive pulmonary disease.
[12765440] Eur Respir J 21(5): 892-905 (2003)
2003  
121
Systemic effects of chronic obstructive pulmonary disease.
[12608452] Eur Respir J 21(2): 347-60 (2003)
2002  
122
Effects of controlled inspiratory muscle training in patients with COPD: a meta-analysis.
[12358330] Eur Respir J 20(3): 570-6 (2002)
2002  
123
Noninvasive ventilation in chronic ventilatory failure due to chronic obstructive pulmonary disease.
[12358321] Eur Respir J 20(3): 511-4 (2002)
2002  
124
Scientific rationale for inhaled combination therapy with long-acting beta2-agonists and corticosteroids.
[11843317] Eur Respir J 19(1): 182-91 (2002)
2001  
125
Noninvasive ventilation and obstructive lung diseases.
[11491176] Eur Respir J 17(6): 1271-81 (2001)
1995  
126
Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force.
[7489808] Eur Respir J 8(8): 1398-420 (1995)
2002  
127
Pathology and pathophysiology of chronic obstructive pulmonary disease.
[11993785] Intern Med 41(4): 265-9 (2002)
2008  
128
Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis.
[19033591] JAMA 300(20): 2407-16 (2008)
2003  
129
Contemporary management of chronic obstructive pulmonary disease: scientific review.
[14600189] JAMA 290(17): 2301-12 (2003)
2008  
130
Chronic obstructive pulmonary disease: an evidence-based approach to treatment with a focus on anticholinergic bronchodilation.
[18990323] Mayo Clin Proc 83(11): 1241-50 (2008)
2007  
131
Cost-effectiveness of long-acting bronchodilators for chronic obstructive pulmonary disease.
[17493425] Mayo Clin Proc 82(5): 575-82 (2007)
2004  
132
Chronic obstructive pulmonary disease: the clinical management of an acute exacerbation.
[15356350] Postgrad Med J 80(947): 497-505 (2004)
2008  
133
Treatment of chronic obstructive pulmonary disease and its comorbidities.
[19017740] Proc Am Thorac Soc 5(8): 848-56 (2008)
2008  
134
Comorbidities in chronic obstructive pulmonary disease.
[18453370] Proc Am Thorac Soc 5(4): 549-55 (2008)
2008  
135
Cardiac disease in chronic obstructive pulmonary disease.
[18453369] Proc Am Thorac Soc 5(4): 543-8 (2008)
2008  
136
Acute exacerbations and respiratory failure in chronic obstructive pulmonary disease.
[18453367] Proc Am Thorac Soc 5(4): 530-5 (2008)
2008  
137
Oxygen therapy in chronic obstructive pulmonary disease.
[18453364] Proc Am Thorac Soc 5(4): 513-8 (2008)
2008  
138
New concepts in the pathobiology of chronic obstructive pulmonary disease.
[18453359] Proc Am Thorac Soc 5(4): 478-85 (2008)
2008  
139
Lung transplantation and lung volume reduction surgery versus transplantation in chronic obstructive pulmonary disease.
[18453354] Proc Am Thorac Soc 5(4): 447-53 (2008)
2007  
140
Pathogen-directed therapy in acute exacerbations of chronic obstructive pulmonary disease.
[18073397] Proc Am Thorac Soc 4(8): 647-58 (2007)
2007  
141
Diagnosis of pathogens in exacerbations of chronic obstructive pulmonary disease.
[18073396] Proc Am Thorac Soc 4(8): 642-6 (2007)
2007  
142
Exacerbations of chronic obstructive pulmonary disease.
[17878469] Proc Am Thorac Soc 4(7): 554-64 (2007)
2007  
143
The nonpharmacologic treatment of chronic obstructive pulmonary disease: advances in our understanding of pulmonary rehabilitation.
[17878468] Proc Am Thorac Soc 4(7): 549-53 (2007)
2007  
144
Pharmacologic therapy: novel approaches for chronic obstructive pulmonary disease.
[17878467] Proc Am Thorac Soc 4(7): 543-8 (2007)
2007  
145
Inhaled corticosteroids in chronic obstructive pulmonary disease.
[17878466] Proc Am Thorac Soc 4(7): 535-42 (2007)
2007  
146
Pharmacologic interventions in chronic obstructive pulmonary disease: bronchodilators.
[17878465] Proc Am Thorac Soc 4(7): 526-34 (2007)
2007  
147
Systemic effects of chronic obstructive pulmonary disease: what we know and what we don't know (but should).
[17878464] Proc Am Thorac Soc 4(7): 522-5 (2007)
2007  
148
The immunopathogenesis of chronic obstructive pulmonary disease: insights from recent research.
[17878463] Proc Am Thorac Soc 4(7): 512-21 (2007)
2004  
149
Role of viruses in exacerbations of chronic obstructive pulmonary disease.
[16113423] Proc Am Thorac Soc 1(2): 115-20 (2004)
2008  
150
Diaphragm adaptations in patients with COPD.
[18218129] Respir Res 9(-): 12 (2008)
2007  
151
Exacerbations of chronic obstructive pulmonary disease: when are antibiotics indicated? A systematic review.
[17407610] Respir Res 8(-): 30 (2007)
2003  
152
2002  
153
Management of chronic obstructive pulmonary disease: the Swiss guidelines. Official Guidelines of the Swiss Respiratory Society.
[11971200] Swiss Med Wkly 132(5-6): 67-78 (2002)
2002  
154
Genetic risk factors of chronic obstructive pulmonary disease.
[11953903] Swiss Med Wkly 132(3-4): 27-37 (2002)
2006  
155
Tiotropium for stable chronic obstructive pulmonary disease: A meta-analysis.
[16844726] Thorax 61(10): 854-62 (2006)
2006  
156
COPD exacerbations.5: management.
[16738044] Thorax 61(6): 535-44 (2006)
2006  
157
COPD exacerbations . 3: Pathophysiology.
[16565268] Thorax 61(4): 354-61 (2006)
2006  
158
COPD exacerbations . 2: aetiology.
[16517585] Thorax 61(3): 250-8 (2006)
2004  
159
Chronic obstructive pulmonary disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care.
[15041752] Thorax 59 Suppl 1(-): 1-232 (2004)
2003  
160
Chronic obstructive pulmonary disease. 10: Bullectomy, lung volume reduction surgery, and transplantation for patients with chronic obstructive pulmonary disease.
[12832685] Thorax 58(7): 634-8 (2003)
2003  
161
Chronic obstructive pulmonary disease . 6: The aetiology of exacerbations of chronic obstructive pulmonary disease.
[12511727] Thorax 58(1): 73-80 (2003)
2002  
162
Chronic obstructive pulmonary disease. 4: imaging the lungs in patients with chronic obstructive pulmonary disease.
[12403883] Thorax 57(11): 982-5 (2002)
1981  
163
Development of secondary polycythaemia in chronic airways obstruction.
[7031963] Thorax 36(5): 321-5 (1981)
1997  
164
Radiology of obstructive pulmonary disease.
[9275869] AJR Am J Roentgenol 169(3): 637-47 (1997)
2008  
165
Smoking-related interstitial lung disease: radiologic-clinical-pathologic correlation.
[18794314] Radiographics 28(5): 1383-96; discussion 1396-8 (2008)
1988  
166
Chronic obstructive pulmonary disease.
[3278783] CMAJ 138(6): 503-10 (1988)
2003  
167
Non-invasive ventilation in chronic obstructive pulmonary disease.
[12543819] BMJ 326(7382): 177-8 (2003)
2005  
168
Recent developments in inhaled therapy in stable chronic obstructive pulmonary disease.
[15774995] BMJ 330(7492): 640-4 (2005)
2006  
169
ABC of chronic obstructive pulmonary disease. Future treatments.
[16873860] BMJ 333(7561): 246-8 (2006)
2006  
170
ABC of chronic obstructive pulmonary disease. Primary care and palliative care.
[16858049] BMJ 333(7560): 188-90 (2006)
2006  
171
ABC of chronic obstructive pulmonary disease. Ventilatory support.
[16840478] BMJ 333(7559): 138-40 (2006)
2004  
172
Chronic obstructive pulmonary disease and sleep.
[14733621] Respir Care 49(1): 39-51; discussion 51-2 (2004)
2004  
173
Surgical therapies for chronic obstructive pulmonary disease.
[14733622] Respir Care 49(1): 53-61; discussion 61-3 (2004)
2004  
174
Chronic obstructive pulmonary disease: emerging medical therapies.
[14733623] Respir Care 49(1): 64-9; discussion 69-71 (2004)
2004  
175
Noninvasive ventilation for chronic obstructive pulmonary disease.
[14733624] Respir Care 49(1): 72-87; discussion 87-9 (2004)
2004  
176
Managing acute respiratory failure during exacerbation of chronic obstructive pulmonary disease.
[15222909] Respir Care 49(7): 766-82 (2004)
2009  
177
Hallway versus treadmill 6-minute-walk tests in patients with chronic obstructive pulmonary disease.
[19961638] Respir Care 54(12): 1712-6 (2009)
2003  
178
Exacerbations of chronic obstructive pulmonary disease.
[14651761] Respir Care 48(12): 1204-13; discussion 1213-5 (2003)
2007  
179
Inhaled corticosteroids in obstructive airway disease.
[17594729] Respir Care 52(7): 852-8 (2007)
2007  
180
Inhaled adrenergics and anticholinergics in obstructive lung disease: do they enhance mucociliary clearance?
[17716384] Respir Care 52(9): 1159-73; discussion 1173-5 (2007)
2007  
181
Conventional chest physical therapy for obstructive lung disease.
[17716386] Respir Care 52(9): 1198-206; discussion 1206-9 (2007)
2009  
182
Getting back to the basics: administering inhaled bronchodilators.
[19327178] Respir Care 54(4): 455-7 (2009)
2009  
183
The 2007 GOLD Guidelines: a comprehensive care framework.
[19650945] Respir Care 54(8): 1040-9 (2009)
2006  
184
Heliox and noninvasive positive-pressure ventilation: a role for heliox in exacerbations of chronic obstructive pulmonary disease?
[16723041] Respir Care 51(6): 640-50 (2006)
2006  
185
Interpretation of spirometry: we can do better than the GOLD standard.
[16800903] Respir Care 51(7): 719-21 (2006)
2002  
186
Exacerbations: etiology and pathophysiologic mechanisms.
[12010842] Chest 121(5 Suppl): 136S-141S (2002)
2010  
187
Chronic macrolide therapy in inflammatory airways diseases.
[21051396] Chest 138(5): 1202-12 (2010)
2004  
188
2004  
189
Inhaled combination therapy with long-acting beta 2-agonists and corticosteroids in stable COPD.
[15249466] Chest 126(1): 220-37 (2004)
2004  
190
Therapeutic responses in asthma and COPD. Bronchodilators.
[15302773] Chest 126(2 Suppl): 125S-137S; discussion 159S-161S (2004)
2004  
191
Therapeutic responses in asthma and COPD. Corticosteroids.
[15302774] Chest 126(2 Suppl): 138S-149S; discussion 159S-161S (2004)
2007  
192
Lung development and adult lung diseases.
[17699136] Chest 132(2): 651-6 (2007)
2007  
193
A systematic review of randomized controlled trials examining the short-term benefit of ambulatory oxygen in COPD.
[17218587] Chest 131(1): 278-85 (2007)
2007  
194
Inhaled steroids and outcomes in COPD: progressing beyond FEV1.
[17356076] Chest 131(3): 648-9 (2007)
2007  
195
A pooled analysis of FEV1 decline in COPD patients randomized to inhaled corticosteroids or placebo.
[17356080] Chest 131(3): 682-9 (2007)
2009  
196
Statins in COPD: a systematic review.
[19376844] Chest 136(3): 734-43 (2009)
2008  
197
Long-acting bronchodilators in COPD.
[18460507] Chest 133(5): 1057-8 (2008)
2009  
198
Safety and efficacy of combined long-acting beta-agonists and inhaled corticosteroids vs long-acting beta-agonists monotherapy for stable COPD: a systematic review.
[19633090] Chest 136(4): 1029-38 (2009)
2005  
199
Pathogenesis of chronic obstructive pulmonary disease.
[16267346] Proc Am Thorac Soc 2(4): 258-66; discussion 290-1 (2005)
2009  
200
What drives the peripheral lung-remodeling process in chronic obstructive pulmonary disease?
[20008873] Proc Am Thorac Soc 6(8): 668-72 (2009)
2009  
201
The origins of asthma and chronic obstructive pulmonary disease in early life.
[19387029] Proc Am Thorac Soc 6(3): 272-7 (2009)
2008  
202
Inhaled and systemic corticosteroids in chronic obstructive pulmonary disease.
[18453363] Proc Am Thorac Soc 5(4): 506-12 (2008)
2006  
203
State of the art. Apoptosis and cell homeostasis in chronic obstructive pulmonary disease.
[16921132] Proc Am Thorac Soc 3(6): 512-6 (2006)
2006  
204
State of the art. Bronchiolitis in chronic obstructive pulmonary disease.
[16921123] Proc Am Thorac Soc 3(6): 489-93 (2006)
2005  
205
Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease.
[16227327] Thorax 60(12): 992-7 (2005)
2003  
206
Chronic obstructive pulmonary disease . 7: Management of COPD.
[12612309] Thorax 58(3): 261-5 (2003)
2007  
207
Biomarkers in COPD: time for a deep breath.
[17687095] Thorax 62(8): 657-60 (2007)
2007  
208
Pathological networking: a new approach to understanding COPD.
[17687100] Thorax 62(8): 733-8 (2007)
2007  
209
What is (and what is not) a COPD exacerbation: thoughts from the new GOLD guidelines.
[17329557] Thorax 62(3): 198-9 (2007)
2008  
210
Proportional classifications of COPD phenotypes.
[18728201] Thorax 63(9): 761-7 (2008)
2005  
211
Pulmonary hypertension in chronic obstructive pulmonary disease: current theories of pathogenesis and their implications for treatment.
[15994270] Thorax 60(7): 605-9 (2005)
2008  
212
Novel long-acting bronchodilators for COPD and asthma.
[18604231] Br J Pharmacol 155(3): 291-9 (2008)
2009  
213
Dual PDE3/4 inhibitors as therapeutic agents for chronic obstructive pulmonary disease.
[19508401] Br J Pharmacol 157(6): 892-906 (2009)
2006  
214
Update in chronic obstructive pulmonary disease 2005.
[16679444] Am J Respir Crit Care Med 173(10): 1056-65 (2006)
2010  
215
Update in chronic obstructive pulmonary disease 2009.
[20335383] Am J Respir Crit Care Med 181(7): 655-60 (2010)
2007  
216
Oxygen therapy in COPD: what do we know?
[17675448] Am J Respir Crit Care Med 176(4): 321-2 (2007)
2007  
217
Are beta2-agonists safe in patients with acute exacerbations of COPD?
[17675449] Am J Respir Crit Care Med 176(4): 322-3 (2007)
2007  
218
Diaphragm muscle fiber dysfunction in chronic obstructive pulmonary disease: toward a pathophysiological concept.
[17413128] Am J Respir Crit Care Med 175(12): 1233-40 (2007)
2007  
219
Update in chronic obstructive pulmonary disease 2006.
[17545457] Am J Respir Crit Care Med 175(12): 1222-32 (2007)
2008  
220
Dendritic cells in chronic obstructive pulmonary disease: new players in an old game.
[18337593] Am J Respir Crit Care Med 177(11): 1180-6 (2008)
2008  
221
Beta-blockers are safe in patients with chronic obstructive pulmonary disease, but only with caution.
[18796649] Am J Respir Crit Care Med 178(7): 661-2 (2008)
2009  
222
Vitamin D beyond bones in chronic obstructive pulmonary disease: time to act.
[19164701] Am J Respir Crit Care Med 179(8): 630-6 (2009)
2006  
223
Pulmonary biomarkers in chronic obstructive pulmonary disease.
[16556692] Am J Respir Crit Care Med 174(1): 6-14 (2006)
2011  
224
Tiotropium versus salmeterol for the prevention of exacerbations of COPD.
[21428765] N Engl J Med 364(12): 1093-1103 (2011)
2007  
225
Physical diagnosis of chronic obstructive pulmonary disease.
[18057759] Intern Med 46(23): 1885-91 (2007)
2008  
226
2007  
227
Achieving therapeutic benefits of inhaled corticosteroids/beta2 agonist in chronic obstructive airway disease.
[17637229] Chin Med J (Engl) 120(12): 1097-105 (2007)
2010  
228
Therapeutic implications of the pathophysiology of COPD.
[20190332] Eur Respir J 35(3): 676-80 (2010)
2009  
229
Systemic manifestations and comorbidities of COPD.
[19407051] Eur Respir J 33(5): 1165-85 (2009)
2009  
230
Endocrinological derangements in COPD.
[19797671] Eur Respir J 34(4): 975-96 (2009)
2009  
231
Inhaled corticosteroids in COPD: a case in favour.
[19567598] Eur Respir J 34(1): 10-2 (2009)
2009  
232
Inhaled corticosteroids in COPD: the case against.
[19567599] Eur Respir J 34(1): 13-6 (2009)
2009  
233
Current status of research on osteoporosis in COPD: a systematic review.
[19567604] Eur Respir J 34(1): 209-18 (2009)
2009  
234
Lymphoid follicles in (very) severe COPD: beneficial or harmful?
[19567605] Eur Respir J 34(1): 219-30 (2009)
2006  
235
Cellular and biochemical bases of chronic obstructive pulmonary disease.
[17273614] J Bras Pneumol 32(3): 241-8 (2006)
2011  
236
Pharmacological treatment of COPD.
[21881744] J Bras Pneumol 37(4): 527-43 (2011)
2009  
237
The role of oxidative stress in COPD: current concepts and perspectives.
[20126926] J Bras Pneumol 35(12): 1227-37 (2009)
2003  
238
New treatments for chronic obstructive pulmonary disease.
[15098577] Ann Ist Super Sanita 39(4): 573-82 (2003)
2009  
239
Role of the respiratory muscles in acute respiratory failure of COPD: lessons from weaning failure.
[19407256] J Appl Physiol 107(3): 962-70 (2009)
2009  
240
Respiratory muscle function and activation in chronic obstructive pulmonary disease.
[19390004] J Appl Physiol 107(2): 621-9 (2009)
2010  
241
Systemic inflammation in chronic obstructive pulmonary disease: may adipose tissue play a role? Review of the literature and future perspectives.
[20414465] Mediators Inflamm 2010(-): 585989 (2010)
2010  
242
The role of the phosphodiesterase-4 inhibitor, roflumilast, in chronic obstructive pulmonary disease.
[20150838] Pol Arch Med Wewn 120(1-2): 9-10 (2010)
2005  
243
The pathogenesis of chronic obstructive pulmonary disease: advances in the past 100 years.
[15837726] Am J Respir Cell Mol Biol 32(5): 367-72 (2005)
2007  
244
Palliative care in chronic obstructive pulmonary disease: a review for clinicians.
[17470930] J R Soc Med 100(5): 225-33 (2007)
2009  
245
Heightened endoplasmic reticulum stress in the lungs of patients with chronic obstructive pulmonary disease: the role of Nrf2-regulated proteasomal activity.
[19797762] Am J Respir Crit Care Med 180(12): 1196-207 (2009)
2008  
246
Phosphodiesterase 4 inhibitors in chronic obstructive pulmonary disease: a new approach to oral treatment.
[18341675] Br J Clin Pharmacol 65(6): 803-10 (2008)
2009  
247
Management and prevention of chronic obstructive pulmonary disease exacerbations: a state of the art review.
[19664218] BMC Med 7(-): 40 (2009)
2010  
248
Roflumilast: first phosphodiesterase 4 inhibitor approved for treatment of COPD.
[20689641] Drug Des Devel Ther 4(-): 147-58 (2010)
2004  
249
Heliox in the treatment of chronic obstructive pulmonary disease.
[15496691] Emerg Med J 21(6): 670-5 (2004)
2007  
250
Best evidence topic report. Use of Heliox in the management of acute exacerbation of COPD.
[17183044] Emerg Med J 24(1): 45-8 (2007)
2011  
251
New pharmacological treatments for patients with chronic obstructive pulmonary disease (COPD).
[21475377] Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 155(1): 43-50 (2011)
2003  
252
Rehabilitation for patients with chronic obstructive pulmonary disease: meta-analysis of randomized controlled trials.
[12648254] J Gen Intern Med 18(3): 213-21 (2003)
2011  
253
TRPV4-mediated calcium influx into human bronchial epithelia upon exposure to diesel exhaust particles.
[21245013] Environ Health Perspect 119(6): 784-93 (2011)
2011  
254
Clinical effectiveness of the Respimat inhaler device in managing chronic obstructive pulmonary disease: evidence when compared with other handheld inhaler devices.
[21468167] Int J Chron Obstruct Pulmon Dis 6(-): 129-39 (2011)
2011  
255
Hypoxemia in patients with COPD: cause, effects, and disease progression.
[21660297] Int J Chron Obstruct Pulmon Dis 6(-): 199-208 (2011)
2011  
256
Long-acting β-adrenoceptor agonists in the management of COPD: focus on indacaterol.
[21814459] Int J Chron Obstruct Pulmon Dis 6(-): 237-43 (2011)
2011  
257
Pathogenic triad in COPD: oxidative stress, protease-antiprotease imbalance, and inflammation.
[21857781] Int J Chron Obstruct Pulmon Dis 6(-): 413-21 (2011)
2011  
258
Profile of aclidinium bromide in the treatment of chronic obstructive pulmonary disease.
[22003291] Int J Chron Obstruct Pulmon Dis 6(-): 457-66 (2011)
2011  
259
Determinants of polypharmacy and compliance with GOLD guidelines in patients with chronic obstructive pulmonary disease.
[22069360] Int J Chron Obstruct Pulmon Dis 6(-): 493-501 (2011)
2011  
260
Optimizing management of chronic obstructive pulmonary disease in the upcoming decade.
[21311693] Int J Chron Obstruct Pulmon Dis 6(-): 47-61 (2011)
2011  
261
Changing patterns in long-acting bronchodilator trials in chronic obstructive pulmonary disease.
[21311692] Int J Chron Obstruct Pulmon Dis 6(-): 35-45 (2011)
2011  
262
Nontypeable Haemophilus influenzae in chronic obstructive pulmonary disease and lung cancer.
[21407824] Int J Chron Obstruct Pulmon Dis 6(-): 113-23 (2011)
2011  
263
New therapeutic options in the management of COPD - focus on roflumilast.
[21468165] Int J Chron Obstruct Pulmon Dis 6(-): 147-55 (2011)
2010  
264
Budesonide/formoterol combination in COPD: a US perspective.
[21037960] Int J Chron Obstruct Pulmon Dis 5(-): 357-66 (2010)
2007  
265
Pulmonary epithelium, cigarette smoke, and chronic obstructive pulmonary disease.
[18268916] Int J Chron Obstruct Pulmon Dis 2(4): 409-28 (2007)
2007  
266
2007  
267
Role of angiogenesis and vascular remodeling in chronic obstructive pulmonary disease.
[18268919] Int J Chron Obstruct Pulmon Dis 2(4): 453-62 (2007)
2007  
268
A review of etiologies of depression in COPD.
[18268923] Int J Chron Obstruct Pulmon Dis 2(4): 485-91 (2007)
2007  
269
Perioperative medical management of patients with COPD.
[18268924] Int J Chron Obstruct Pulmon Dis 2(4): 493-515 (2007)
2008  
270
Roles for proteinases in the pathogenesis of chronic obstructive pulmonary disease.
[18686734] Int J Chron Obstruct Pulmon Dis 3(2): 253-68 (2008)
2008  
271
Airways inflammation and treatment during acute exacerbations of COPD.
[18686731] Int J Chron Obstruct Pulmon Dis 3(2): 217-29 (2008)
2008  
272
Investigation of airways using MDCT for visual and quantitative assessment in COPD patients.
[18488432] Int J Chron Obstruct Pulmon Dis 3(1): 97-107 (2008)
2008  
273
Mechanisms of atherothrombosis in chronic obstructive pulmonary disease.
[18488431] Int J Chron Obstruct Pulmon Dis 3(1): 89-96 (2008)
2008  
274
Optimizing antibiotic selection in treating COPD exacerbations.
[18488427] Int J Chron Obstruct Pulmon Dis 3(1): 31-44 (2008)
2008  
275
End of life care in chronic obstructive pulmonary disease: in search of a good death.
[18488426] Int J Chron Obstruct Pulmon Dis 3(1): 11-29 (2008)
2008  
276
Association of chronic obstructive pulmonary disease and obstructive sleep apnea consequences.
[19281082] Int J Chron Obstruct Pulmon Dis 3(4): 671-82 (2008)
2008  
277
2008  
278
ABCD of the phosphodiesterase family: interaction and differential activity in COPD.
[19281073] Int J Chron Obstruct Pulmon Dis 3(4): 543-61 (2008)
2008  
279
Role of T-lymphocytes and pro-inflammatory mediators in the pathogenesis of chronic obstructive pulmonary disease.
[19281072] Int J Chron Obstruct Pulmon Dis 3(4): 531-41 (2008)
2008  
280
Long-acting beta2-agonists (LABA) in chronic obstructive pulmonary disease: efficacy and safety.
[19281071] Int J Chron Obstruct Pulmon Dis 3(4): 521-9 (2008)
2003  
281
Structure and function of the respiratory muscles in patients with COPD: impairment or adaptation?
[14621106] Eur Respir J Suppl 46(-): 41s-51s (2003)
2003  
282
Respiratory failure in chronic obstructive pulmonary disease.
[14621114] Eur Respir J Suppl 47(-): 26s-30s (2003)
2003  
283
Systemic inflammation in chronic obstructive pulmonary disease.
[14621102] Eur Respir J Suppl 46(-): 5s-13s (2003)
2003  
284
Oxidant metabolism in chronic obstructive pulmonary disease.
[14621103] Eur Respir J Suppl 46(-): 14s-27s (2003)
2003  
285
Pulmonary vascular involvement in chronic obstructive pulmonary disease.
[14621104] Eur Respir J Suppl 46(-): 28s-32s (2003)
2003  
286
Fluid homeostasis in chronic obstructive lung disease.
[14621105] Eur Respir J Suppl 46(-): 33s-40s (2003)
2011  
287
Inflammation in COPD: pathogenesis, local and systemic effects.
[21424028] Rom J Morphol Embryol 52(1): 21-7 (2011)
2007  
288
Chronic obstructive pulmonary disease in a new concept.
[17914487] Rom J Morphol Embryol 48(3): 207-14 (2007)
2005  
289
Sputum analysis in diagnosis and management of obstructive airway diseases.
[18360557] Ther Clin Risk Manag 1(3): 169-79 (2005)
2002  
290
Anticholinergics in the treatment of chronic obstructive pulmonary disease.
[12169757] Respiration 69(4): 372-9 (2002)
2011  
291
The epithelial cell and lung cancer: the link between chronic obstructive pulmonary disease and lung cancer.
[21311210] Respiration 81(2): 89-104 (2011)
2011  
292
Chronic obstructive pulmonary disease and lung cancer: new molecular insights.
[21430413] Respiration 81(4): 265-84 (2011)
2003  
293
Newly diagnosed chronic obstructive pulmonary disease. Clinical features and distribution of the novel stages of the Global Initiative for Obstructive Lung Disease.
[12584394] Respiration 70(1): 67-75 (2003)
2007  
294
Tiotropium and the treatment of chronic obstructive pulmonary disease.
[18257166] Can Respir J 14(8): 460-2 (2007)
2008  
295
Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2008 update - highlights for primary care.
[18292855] Can Respir J 15 Suppl A(-): 1A-8A (2008)
2011  
296
Characterization of the bronchodilatory dose response to indacaterol in patients with chronic obstructive pulmonary disease using model-based approaches.
[21518459] Respir Res 12(-): 54 (2011)
2011  
297
Reduction of exacerbations by the PDE4 inhibitor roflumilast--the importance of defining different subsets of patients with COPD.
[21272339] Respir Res 12(-): 18 (2011)
2010  
298
Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents.
[21034447] Respir Res 11(-): 149 (2010)
2011  
299
Extrapulmonary comorbidities in chronic obstructive pulmonary disease: state of the art.
[21955235] Expert Rev Respir Med 5(5): 647-62 (2011)
2010  
300
Autophagy in cigarette smoke-induced chronic obstructive pulmonary disease.
[20923337] Expert Rev Respir Med 4(5): 573-84 (2010)
2005  
301
Use of spirometry for case finding, diagnosis, and management of chronic obstructive pulmonary disease (COPD).
[16238364] Evid Rep Technol Assess (Summ) -(121): 1-7 (2005)
2011  
302
The 2010 NICE COPD Guidelines: how do they compare with the GOLD guidelines?
[21437566] Prim Care Respir J 20(2): 199-204 (2011)
2010  
303
The ADMIT series - Issues in inhalation therapy. 4) How to choose inhaler devices for the treatment of COPD.
[19890594] Prim Care Respir J 19(1): 10-20 (2010)
2003  
304
Chronic obstructive pulmonary disease due to occupational exposure to silica dust: a review of epidemiological and pathological evidence.
[12660371] Occup Environ Med 60(4): 237-43 (2003)
2005  
305
The role of occupation in the development of chronic obstructive pulmonary disease (COPD).
[15778251] Occup Environ Med 62(4): 212-4 (2005)
2011  
306
Update on pharmaceutical and minimally invasive management strategies for chronic obstructive pulmonary disease.
[21660228] Pulm Med 2011(-): 257496 (2011)
2011  
307
Long-Term Oxygen Therapy in COPD: Factors Affecting and Ways of Improving Patient Compliance.
[21941649] Pulm Med 2011(-): 325362 (2011)
2009  
308
The diagnostic value of history and physical examination for COPD in suspected or known cases: a systematic review.
[19423699] Fam Pract 26(4): 260-8 (2009)
2011  
309
Pharmacotherapies for chronic obstructive pulmonary disease: a multiple treatment comparison meta-analysis.
[21487451] Clin Epidemiol 3(-): 107-29 (2011)
2009  
310
Defining chronic obstructive pulmonary disease in older persons.
[19464159] Respir Med 103(10): 1468-76 (2009)
2009  
311
Inspiratory muscle training in patients with chronic obstructive pulmonary disease: the state of the evidence.
[20467518] Cardiopulm Phys Ther J 20(3): 5-15 (2009)
2009  
312
End stage chronic obstructive pulmonary disease.
[19462352] Pneumonol Alergol Pol 77(2): 173-9 (2009)
2009  
313
Defining disease modification in chronic obstructive pulmonary disease.
[19811377] COPD 6(3): 211-25 (2009)
2004  
314
Non-invasive ventilation in chronic obstructive pulmonary disease.
[15611602] J Physiol Pharmacol 55 Suppl 3(-): 115-9 (2004)
2010  
315
Role of th17 cell and autoimmunity in chronic obstructive pulmonary disease.
[20844734] Immune Netw 10(4): 109-14 (2010)
2010  
316
Airway endothelial dysfunction in asthma and chronic obstructive pulmonary disease: a challenge for future research.
[20709816] Am J Respir Crit Care Med 182(11): 1344-51 (2010)
2010  
317
Autonomic dysfunction in patients with chronic obstructive pulmonary disease (COPD).
[22263050] J Thorac Dis 2(4): 215-22 (2010)
2010  
318
The use of roflumilast in COPD: a primary care perspective.
[21085915] Prim Care Respir J 19(4): 342-51 (2010)
PMC   
319
A blinded evaluation of the efficacy and safety of glycopyrronium, a once-daily long-acting muscarinic antagonist, versus tiotropium, in patients with COPD: the GLOW5 study.
[24438744] BMC Pulm Med 14():4 (2014)
PMC   
320
Plasma YKL-40 and all-cause mortality in patients with chronic obstructive pulmonary disease.
[24373580] BMC Pulm Med 13():77 (2013)
PMC   
321
Recent advances in pre-clinical mouse models of COPD.
[24144354] Clin Sci (Lond) 126(4):253-65 (2014)
PMC   
322
Regadenoson use in patients with chronic obstructive pulmonary disease: the state of current knowledge.
[24489466] Int J Chron Obstruct Pulmon Dis 9():129-37 (2014)
PMC   
323
Role of indacaterol, a once-daily bronchodilator, in chronic obstructive pulmonary disease.
[24409359] J Thorac Dis 5(6):806-14 (2013)
PMC   
324
New GOLD classification: longitudinal data on group assignment.
[24417879] Respir Res 15():3 (2014)
PMC   
325
The unique alterations of hippocampus and cognitive impairment in chronic obstructive pulmonary disease.
[24359080] Respir Res 14():140 (2013)
PMC   
326
Reducing agents decrease the oxidative burst and improve clinical outcomes in COPD patients: a randomised controlled trial on the effects of sulphurous thermal water inhalation.
[24453924] ScientificWorldJournal 2013():927835 (2013)
PMC   
327
Clinical issues of mucus accumulation in COPD.
[24493923] Int J Chron Obstruct Pulmon Dis 9():139-50 (2014)
PMC   
328
Overexpression of CD163, CD204 and CD206 on alveolar macrophages in the lungs of patients with severe chronic obstructive pulmonary disease.
[24498098] PLoS One 9(1):e87400 (2014)
PMC   
329
Update on clinical inflammometry for the management of airway diseases.
[23616969] Can Respir J 20(2):117-20 (2013)
PMC   
330
Pathogenesis of hyperinflation in chronic obstructive pulmonary disease.
[24600216] Int J Chron Obstruct Pulmon Dis 9():187-201 (2014)
PMC   
331
Preferential macrophage recruitment and polarization in LPS-induced animal model for COPD: noninvasive tracking using MRI.
[24598763] PLoS One 9(3):e90829 (2014)
PMC   
332
Clinical application of expectorant therapy in chronic inflammatory airway diseases (Review).
[24660026] Exp Ther Med 7(4):763-767 (2014)
PMC   
333
Airway inflammation in chronic obstructive pulmonary disease.
[24672691] J Thorac Dis 6(Suppl 1):S167-72 (2014)
PMC   
334
Asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): current literature review.
[24672688] J Thorac Dis 6(Suppl 1):S146-51 (2014)
PMC   
335
Musculoskeletal disorders in chronic obstructive pulmonary disease.
[24783225] Biomed Res Int 2014():965764 (2014)
PMC   
336
Acute exacerbation of chronic obstructive pulmonary disease: cardiovascular links.
[24724085] Biomed Res Int 2014():528789 (2014)
PMC   
337
Exhaled nitric oxide as a biomarker in COPD and related comorbidities.
[24719850] Biomed Res Int 2014():271918 (2014)
PMC   
338
Differences in adjustment between individuals with alpha-1 antitrypsin deficiency (AATD)-associated COPD and non-AATD COPD.
[23547634] COPD 10(2):226-34 (2013)
PMC   
339
Plasma inflammatory mediators associated with bone metabolism in COPD.
[20486817] COPD 7(3):186-91 (2010)
PMC   
340
Economic evaluation of aclidinium bromide in the management of moderate to severe COPD: an analysis over 5 years.
[24741321] Clinicoecon Outcomes Res 6():175-85 (2014)
PMC   
341
Clinical benefit of fixed-dose dual bronchodilation with glycopyrronium and indacaterol once daily in patients with chronic obstructive pulmonary disease: a systematic review.
[24729699] Int J Chron Obstruct Pulmon Dis 9():331-8 (2014)
PMC   
342
The role of microparticles in chronic obstructive pulmonary disease.
[24707174] Int J Chron Obstruct Pulmon Dis 9():303-14 (2014)
PMC   
343
Corticosteroid effects on COPD alveolar macrophages: dependency on cell culture methodology.
[24530567] J Immunol Methods 405():144-53 (2014)
PMC   
344
Fish smoking and COPD: A fishy affair.
[24778469] Lung India 31(2):105-6 (2014)
PMC   
345
The importance of the assessment of pulmonary function in COPD.
[22793942] Med Clin North Am 96(4):745-52 (2012)
PMC   
346
The role and potential of imaging in COPD.
[22793941] Med Clin North Am 96(4):729-43 (2012)
PMC   
347
AIMAR survey on COPD phenotypes.
[24635848] Multidiscip Respir Med 9(1):16 (2014)
PMC   
348
Sensitivity of the COPD assessment test (CAT questionnaire) investigated in a population of 681 consecutive patients referring to a lung clinic: the first Italian specific study.
[24629022] Multidiscip Respir Med 9(1):15 (2014)
PMC   
349
Pathogenesis of inflammation and repair in advanced COPD.
[20496295] Semin Respir Crit Care Med 31(3):257-66 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


  • Sozialmedizinische Beurteilung der Leistungsfähigkeit bei chronischer obststruktiver Lungenkrankheit (COPD) und Asthma bronchiale


  • Search PubMed and many other databases on the combined search terms

    GG: copd

  • COPD

  • The BDOM Bibliographic Dictionary of Medicine is a curated collection of free medical articles tagged to concepts.
    Contents until 2011 are reviews from PubMed, contents flagged 'PMC' are regular articles from PubMed Central.
    Search BDOM
    Nephrology Collection
    Radiology Locator

    PubMedCentral monthly collection of free medical articles by major subject

    The framed wikipedia articles are from en.wikipedia.org and they are the actual versions; the first is from Nephropedia